When the Food and Drug Administration published its final rule on March 5, 2026, it set in motion one of the most significant operational changes the pharmaceutical industry has seen in recent memory. The agency’s decision to mandate a uniform 12-digit National Drug Code (NDC) format represents far more than a simple technical adjustment—it’s a fundamental restructuring of how drugs are identified, tracked, and managed throughout the American healthcare ecosystem.

The pharmaceutical industry is navigating one of its most significant operational transformations in decades. As the Drug Supply Chain Security Act (DSCSA) enforcement period matures, companies are discovering that compliance success hinges on details many initially overlooked—chief among them, how they identify and communicate location data across their trading partner networks.